|Orvis UK /Conservation UK - Canine Cancer Campaign|
The Orvis Commitment
Canine Cancer Campaign
Canine Cancer. Half of all dogs will develop cancer and 1 in 4 will die from it. Fortunately, in recent years, veterinary scientists have made tremendous strides in the area of canine cancer research. Recent studies have led to new tools for scientists studying canine cancer, better diagnostics and improved chemotherapy treatments. But there is much more work to be done. That's why The Orvis Company has partnered with Morris Animal Foundation, a nonprofit organization that invests in animal health science, to support canine cancer research and improve the health of dogs. Since this partnership began, Orvis and its customers have raised more than $800,000 for science that advances the health of dogs.
What's Being Done
As of March 2013, Orvis and our customers have raised more than $800,000 to help fund canine cancer research. Morris Animal Foundation—the global leader in supporting scientific research that advances veterinary medicine—has used these funds to develop early cancer-detection tests and safer and more effective chemotherapy protocols for dogs. To aid researchers and continue this important work, the MAF developed a tumor tissue bank for common canine cancers. They have helped fund 150 canine cancer studies at 28 colleges and universities. Going forward, the MAF is also committed to funding the Canine Lifetime Health Project and the groundbreaking Golden Retriever Lifetime Study.
Your continued support will help create a brighter future for dogs.
The adorable golden retreiver you see at the top is our friend Louie.